Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021

SELL
$165.87 - $220.95 $8,625 - $11,489
-52 Closed
0 $0
Q1 2021

May 07, 2021

BUY
$180.37 - $226.26 $3,607 - $4,525
20 Added 62.5%
52 $10,000
Q4 2020

Jan 13, 2021

BUY
$148.08 - $206.57 $3,702 - $5,164
25 Added 357.14%
32 $6,000
Q3 2020

Nov 12, 2020

BUY
$122.51 - $158.27 $857 - $1,107
7 New
7 $1,000
Q1 2020

May 12, 2020

SELL
$84.96 - $109.14 $764 - $982
-9 Closed
0 $0
Q4 2019

Feb 07, 2020

SELL
$73.84 - $93.08 $664 - $837
-9 Reduced 50.0%
9 $0
Q3 2019

Nov 14, 2019

BUY
$76.65 - $95.51 $1,379 - $1,719
18 New
18 $1,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.32B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Sowell Financial Services LLC Portfolio

Follow Sowell Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.